In this study, the regulation of ORMDL3 gene expression that might affect the sensitivity of HCC cells to sorafenib treatment was first examined, and the particular mechanism of inhibiting autophagy through the PERK-ATF4-Beclin1 pathway was elucidated. This evidence concerns the gene ATF4 and hepatocellular carcinoma.